Company intelligence / Profile preview

Cascara Ventures

Brussels, Brussels-Capital Region, Belgiumcascaraventures.com ↗

Ownership: Private
Development stage: Other

Overview

Cascara Ventures is a Brussels-based venture capital fund founded in 2016 by Adriaan Hart de Ruijter. The firm specializes in early-stage investments (seed and Series A) for life sciences and healthcare technology startups. Its investment focus includes vaccines, medical devices, pharmaceuticals, imaging technologies, software/data solutions for healthcare, robotics, diagnostics, cell therapies and related fields. The fund leverages deep regulatory and clinical development expertise to support its portfolio.

Modalities: Small moleculeMonoclonal antibodyCell therapyMedical device
Industry: Investors

Partnerships

European Investment Fund (EIF) – co-investment/matching partnerHigh-Tech GründerfondsBayern Kapital GmbHVTT VenturesThuja Capital

Beyond the preview

Go deeper on Cascara Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cascara Ventures.

Explore the full profile